Pictures of people affected by ectodermal dysplasias for the 2024 NFEDImpact Report
A word from our executive director and board chair

As we look back on 2024, we are filled with gratitude and hope. This year, more families reached out to the NFED than ever before—a 29% increase—and our community now spans 121 countries. Behind every number is a person with a story: children smiling with new confidence after receiving their first set of dentures, a family embraced at our conference after a new diagnosis, and a young adult bravely sharing with lawmakers and researchers as they advocate for critical legislation through the Ensuring Lasting Smiles Act (ELSA).

Thanks to your support, we sustained vital programs while staying true to our highly relational approach to our community. We launched new mental health resources, moved research forward, and supported families navigating a life-changing clinical trial. 

Because of you, families find hope, answers, and connection. Together, we are building a brighter future for everyone affected by ectodermal dysplasias. We couldn’t be more thankful!

Picture of MAry Fete, Executive Director, and KArl Nelsen, President of the Bpard for 2024 NFED Impact Report
Picture of kids for 2024 NFEDImpact Report
Picture of two advocates for ELSA
Picture of a toddler participating in EDELIFE Clinical Trial

A new prevalence study helped us raise awareness and affirm that every person affected deserves dignity, respect, and lasting solutions.

Picture of two cute kids  with smiles 2024 NFEDImpact Report

From a new school advocacy toolkit to dozens of educational articles and stories, we gave families the resources they needed.

School Advocacy Toolkit cover image

New staff and a smarter structure helped us serve families better, support research, and sustain essential programs.

Family celebrating their daughter's dentures 2024 NFEDImpact Report
Maddie and her mom and dad for the dental treatment story 2024 NFEDImpact Report

Maddie’s Smile Story

“When Maddie entered into sixth grade, she felt super happy with her new, in-progress smile, so much so that in her school picture she shared a very toothy smile – the first ever!…What initially felt overwhelming became more manageable with the invaluable guidance of the NFED and its network of amazing doctors.”  

Beth, Maddie’s mom

Title: Education and Support
Members of our community smiling for the 2024 NFEDImpact Report

In 2024, the NFED welcomed 437 new individuals and 98 families, expanding our community and deepening our impact. We strengthened emotional support services through new surveys and partnerships, including launching Wellness4Rare with the Canadian Ectodermal Dysplasia Syndromes Association (CEDSA) and Global Genes. Our Treatment Assistance Program continued helping families access critical care, we grew our young adult outreach, and offered individuals support through our online groups. Every milestone reflects your generosity and assures nobody has to face a diagnosis of ectodermal dysplasia alone.

Marianne and her son Peter at the mountains with her husband
advocacy

​​Advocacy at the NFED goes beyond policy. It’s about empowering families to speak up in everyday moments. In 2024, 63 families used our School Advocacy Packet to promote inclusion in classrooms. We raised awareness globally, sharing stories that sparked change. At the Stand Together Advocacy Conference, 254 advocates from 35 states united in Washington, D.C. explored how to create impact at school, work, and doctor visits. Advocates have taken a total of 30,987 actions using our advocacy tool to reach out to U.S. members of Congress, and we’ve reached 1,142 registered NFED advocates committed to taking action to pass the bill. We continued championing the ELSA, pushing for insurance coverage for congenital conditions. Together, we’re elevating the realities faced by all individuals affected by ectodermal dysplasias so they have what they need to thrive.

picture of 200+ people gathered on Capitol steps for the advocacy day on the hill
Two board members smiling for 2024 NFEDImpact Report

In 2024, research remained central to the NFED’s mission, driven by the voices and needs of our community. We hosted the  Complex Wounds in Ectodermal Dysplasias Conference at Children’s Hospital of Philadelphia, uniting nearly 40 experts to tackle complex wounds in p63 syndromes. We also prepared for the 2025 Incontinentia Pigmenti Conference: Translating Discovery to Therapy to address a major gap in research and care for this often overlooked syndrome. The NFED funded a new mobile app study and laid the foundation for an innovative wound healing research study. Once initiated, families will track wound healing in real time by uploading photos every two weeks. Each initiative brings us closer to answers and treatments.

Two advocates, one who is pregnant, meeting with their congressperson in D.C.

Among the over 250 NFED advocates at The Stand Together Advocacy Conference in uniting to support ELSA in Washington, D.C., was  Alex and Alexa, who were expecting their first child who would be born with a type of ectodermal dysplasia. Seeking answers, they traveled from Hawaii to find community and advocate for change. Their story, like so many others, added urgency to 159 meetings with lawmakers. Together, our advocates shared their challenges and hopes. Every voice mattered. Every story inspired. Together, we’re fighting for ELSA—and for every person’s right to the care they need.

Picture of staff and Scientific Advisory Council members at a research conference

In October, 40 experts from four countries gathered at the NFED’s Complex Wounds in Ectodermal Dysplasias Conference at CHOP to explore solutions for painful skin erosions. Inspired by stories like Ryan’s—born with AEC syndrome and 70% of his skin eroded—researchers discussed paths toward real and innovative therapies. “I was blown away,” said Ruth, Ryan’s mom. “It was a truly special, even overwhelming, experience. It makes you feel like there’s good people in the world!” The conference was co-hosted by Drs. Eric Liao and Maranke Koster and made possible by Bruce and Alice Geismar and Oracle America, Inc.

cute kiddo whop was a participant in the EDELIFE clinical trial

The Edelife Clinical Trial offers new hope for families affected by x-linked hypohidrotic ectodermal dysplasia (XLHED). For the first time, a treatment given before birth may prevent core symptoms—like the inability to sweat. As of 2024, ten babies had received the therapy, bringing us closer to our goal of 20. Parents like Elizabeth and John, who enrolled in the trial, have experienced the success of this trial firsthand- their son Jack sweats! Thanks to your support, the NFED connects families like theirs, provides vital education, and offers ongoing support as they participate and dream of a better future for all who face a diagnosis of XLHED.

Together we did more - NFED 2024 Impact Report Numbers Graphic
Together we did more - NFED 2024 Impact Report Financial Graphic
graphic of our road forward for 2024 NFED Impact Report

Because of you, lives are being enriched. Your kindness and generosity helped individuals and families receive the care, support, and answers they need. Throughout the year, we shared opportunities to give and to make a difference—and you showed up. Every gift—big or small—helped provide vital education, research, treatment, advocacy, and so much more. We are deeply grateful for your trust and belief in our mission. You are part of this story, this impact, and this community. Thank you for standing with us. Together, we’re building a future full of hope and possibility.

National Health Council
President's Volunteer Service Award
Four-Star Charity Navigator
Silver Transparency for Candid
Genetic Alliance
Coalition of Skin Diseases
Pediatric Dermatology Research Alliance
Ectodermal Dysplasias International Network
Blobal Genese
National Organization for Rare Disorders